Trials / Terminated
TerminatedNCT02997696
A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase 2, randomised, double-blind, placebo controlled, parallel group, multicentre study is to investigate the efficacy, safety, tolerability and pharmacokinetics of a compound ONO-4474 in patients with moderate to severe pain due to osteoarthritis of the knee following 4 weeks of oral administration of ONO-4474.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-4474 | |
| DRUG | Placebo matching ONO-4474 |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-01-09
- Completion
- 2018-01-09
- First posted
- 2016-12-20
- Last updated
- 2018-02-26
Locations
47 sites across 5 countries: Denmark, Hungary, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02997696. Inclusion in this directory is not an endorsement.